| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/11/2002 | CA2432504A1 Methods and compositions for treating periodontal disease |
| 07/11/2002 | CA2432184A1 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 07/10/2002 | EP1221615A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
| 07/10/2002 | EP1221490A2 Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars |
| 07/10/2002 | EP1221484A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/10/2002 | EP1221443A1 Substituted imidazolidinone derivatives |
| 07/10/2002 | EP1221440A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 07/10/2002 | EP1221326A2 Nitric oxide donors capable of reducing toxicity from drugs |
| 07/10/2002 | EP1221314A1 New crystalline form of omeprazole |
| 07/10/2002 | EP1220948A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 07/10/2002 | EP1220947A2 50 human secreted proteins |
| 07/10/2002 | EP1220942A1 41 human secreted proteins |
| 07/10/2002 | EP1220932A1 Human carboxypeptidases and polynucleotides encoding the same |
| 07/10/2002 | EP1220922A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 07/10/2002 | EP1220901A1 26 human secreted proteins |
| 07/10/2002 | EP1220900A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 07/10/2002 | EP1220872A1 Uroguanylin as an intestinal cancer inhibiting agent |
| 07/10/2002 | EP1220869A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 07/10/2002 | EP1220865A1 43 human secreted proteins |
| 07/10/2002 | EP1220863A1 Purine derivatives |
| 07/10/2002 | EP1220862A1 Purine derivatives |
| 07/10/2002 | EP1220857A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/10/2002 | EP1220856A2 Pyrazolo[4,3-d]pyrimidine derivatives |
| 07/10/2002 | EP1220855A2 Anhydrous salt |
| 07/10/2002 | EP1220852A1 Substituted diazepans |
| 07/10/2002 | EP1220845A1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors |
| 07/10/2002 | EP1220844A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 07/10/2002 | EP1220843A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 07/10/2002 | EP1220839A2 Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors |
| 07/10/2002 | EP1220831A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 07/10/2002 | EP1220830A1 Systems and methods for opening obstructed biological conduits |
| 07/10/2002 | EP1220684A2 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/10/2002 | EP1220683A2 Mycophenolate mofetil in association with peg-ifn-alpha |
| 07/10/2002 | EP1220672A1 Medicament for treatment of neuropathies |
| 07/10/2002 | EP1220617A1 Fish feed with increased nucleotide content |
| 07/10/2002 | CN1358228A Polynucleotide and deduced amino acid sequences from stromal cells |
| 07/10/2002 | CN1358193A Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/10/2002 | CN1358192A 嘌呤衍生物 Purine derivatives |
| 07/10/2002 | CN1358188A Diphosphate salt of A4'-substituted-9-deoxo-9A-aza 9A-homoerythromycin derivative and its pharmaceutical composition |
| 07/10/2002 | CN1358178A Pharmaceutical compounds |
| 07/10/2002 | CN1358097A Anionic polymers as toxin binders and antibacterial agents |
| 07/10/2002 | CN1358089A Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
| 07/10/2002 | CN1357623A Prepn of active haparin |
| 07/10/2002 | CN1357381A Dressed medicine for treating hernia |
| 07/10/2002 | CN1357380A Gastrosis treating medicine |
| 07/10/2002 | CN1357379A Toothache treating medicine |
| 07/10/2002 | CN1357374A Compounding process of ginseng green Huajing |
| 07/10/2002 | CN1357372A Chine medicine ointment for treating stomatopathy |
| 07/10/2002 | CN1357371A Name, recipe and prepn proces sof body-scenting and face-beautifying capsule |
| 07/10/2002 | CN1357363A Malian granule for clearing away liver fire |
| 07/10/2002 | CN1357362A Stone-eliminating Jinyin medicine powder |
| 07/10/2002 | CN1357347A Chinese medicine with physique enhancing and disease treating functions |
| 07/10/2002 | CN1357343A Medicine bolus for treaitng Yin-deficiency constipation |
| 07/10/2002 | CN1357341A Cholelithiasis treating medicine |
| 07/10/2002 | CN1357336A Mixed Chinese medicine prepn for treating chronic atrophied gastritis and its preparing method |
| 07/10/2002 | CN1357332A Application of double-stranded ribonucleic acid in prepairng medicine for treaitng hepatic tumor and hepatitis B |
| 07/10/2002 | CN1357311A Medical application of ursolic acid |
| 07/10/2002 | CN1087344C Transforming growth factor alpha-H1 |
| 07/10/2002 | CN1087285C Basic group substituted benzoyl guaniazine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same |
| 07/09/2002 | US6417393 Treatment of sickle-cell anemia, brain edema from tumors or ischemia, diarrhea, and glaucoma; hypotensive, wound healing, antiinflammatory and antiallergen agents |
| 07/09/2002 | US6417349 Water-soluble extract of asiaticoside and madecassoside from Centella asiatica and isolating method thereof |
| 07/09/2002 | US6417232 Fatty acid analogues for the treatment of primary and secondary restenosis |
| 07/09/2002 | US6417227 Methods of delivery of cetyl myristoleate |
| 07/09/2002 | US6417219 Enzyme inhibitors and osteoarthritis |
| 07/09/2002 | US6417218 Substituted imidazoles, their preparation and use |
| 07/09/2002 | US6417214 Compounds as contraceptives |
| 07/09/2002 | US6417188 Arylalkanoylpyridazines |
| 07/09/2002 | US6417170 Administering to skin a composition containing deoxyribonucleosides in concentrations sufficient to enhance dna repair or reduce mutation frequency in a vehicle capable of delivering deoxyribonucleosides to skin cells |
| 07/09/2002 | US6416991 Genetic engineered protein |
| 07/09/2002 | US6416765 Botulinum toxin injected into the pancreas |
| 07/09/2002 | CA2303132C Intranasal formulations containing scopolamine and method of treating motion sickness |
| 07/09/2002 | CA2041224C Azatetracycle compounds |
| 07/05/2002 | CA2367001A1 The method for production of egg containing anti-e.coli igy and anti-helicobacter pylori igy and anti-salmonella enteritidis igy and anti-salmonella typhimurium igy simultaneously, and egg, yolk, yogurt and ice cream containing specific igy for anti-e.coli, anti-helicobacter pylori, anti-salmonella enteritidis and anti-salmonella typhimurium |
| 07/04/2002 | WO2002051999A1 Novel atopic dermatitis-associated gene and proteins |
| 07/04/2002 | WO2002051855A2 Motilide compounds |
| 07/04/2002 | WO2002051848A2 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors |
| 07/04/2002 | WO2002051844A1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 07/04/2002 | WO2002051841A1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
| 07/04/2002 | WO2002051837A2 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2002 | WO2002051836A1 Dipeptidyl peptidase iv inhibitor |
| 07/04/2002 | WO2002051835A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 07/04/2002 | WO2002051814A1 Benzoylpyridazines |
| 07/04/2002 | WO2002051807A1 Compounds |
| 07/04/2002 | WO2002051806A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 07/04/2002 | WO2002051442A1 Concomitant drugs |
| 07/04/2002 | WO2002051440A1 Combination drugs |
| 07/04/2002 | WO2002051435A2 New therapeutic uses of smr1 peptides |
| 07/04/2002 | WO2002051434A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 07/04/2002 | WO2002051425A1 Remedies for hepatitis c |
| 07/04/2002 | WO2002051418A1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
| 07/04/2002 | WO2002051411A1 Famotidine injections |
| 07/04/2002 | WO2002051404A1 Compositions for oral use |
| 07/04/2002 | WO2002051398A1 Choline pyruvate, method for the production thereof, formulations containing choline pyruvate and the use thereof |
| 07/04/2002 | WO2002051384A1 Method of stabilizing suspension and stabilized suspension |
| 07/04/2002 | WO2002033100A3 Regulation of human adenylate cyclase, type iv |
| 07/04/2002 | WO2002015904B1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections |
| 07/04/2002 | WO2002002716A8 Cubic liquid crystalline compositions and methods for their preparation |
| 07/04/2002 | WO2001091682A8 Composition and applicator for topical substance delivery |
| 07/04/2002 | WO2001078779A3 Antibody alpha4beta7 integrin and its use to treat inflammatory bowel disease |
| 07/04/2002 | WO2001078768A3 Targeted vaccine delivery systems |